Phase II study of TAS-OX (TAS-102 and oxaliplatin) plus bevacizumab for late-line colorectal cancer.
- Resource Type
- Article
- Authors
- Hochster, Howard S.; Liu, Hao; Berim, Lyudmyla Derby; Spencer, Kristen Renee; Gulhati, Pat; DiRubbo, Manda; Cohen, Seth D.; Lee, Patrick; Leitner, Stuart P.; Radovich, Delia; Misdary, Christian; Perez, Christian; Datta, Sutirtha; Gonzalez, Andrea; Saunders, Tracie; Boland, Patrick M
- Source
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p144-144, 1p
- Subject
- Language
- ISSN
- 0732183X